FDA Approves New Use for Lenalidomide in Multiple Myeloma

The FDA has approved lenalidomide for use as a maintenance therapy in patients with multiple myeloma who have undergone an autologous stem cell transplant, to help keep the cancer from coming back.

Cancer Currents: An NCI Cancer Research Blog